ZYVERSA THERAPEUTICS, INC. Derivative, Gain (Loss) on Derivative, Net
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Derivative, Gain (Loss) on Derivative, Net of -$607.00 thousand for the 11-month period ending 2022-12-12, per its 10-K filed 2024-03-25.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2024-03-25
- ZYVERSA THERAPEUTICS, INC. derivative, gain (loss) on derivative, net for fiscal 2021 was $228.10K.
| Period end | Derivative, Gain (Loss) on Derivative, Net 11 month | Derivative, Gain (Loss) on Derivative, Net 11 month as first filed | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|
| 2022-12-12 | -$607.00K 10-K · filed 2024-03-25 | $607.00K 10-K · filed 2023-03-31 | |
| 2021-12-31 | $228.10K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |